Cart
sales@molnova.com
SM360320
CAS No. 226907-52-4
SM360320( SM-360320 | SM 360320 | CL-087 | CL 087 | CL087 | 1V136 )
Catalog No. M27128 CAS No. 226907-52-4
SM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 385 | Get Quote |
|
| 10MG | 575 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1233 | Get Quote |
|
| 100MG | 1647 | Get Quote |
|
| 500MG | 3321 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSM360320
-
NoteResearch use only, not for human use.
-
Brief DescriptionSM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.
-
DescriptionSM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.
-
In Vitro——
-
In Vivo——
-
SynonymsSM-360320 | SM 360320 | CL-087 | CL 087 | CL087 | 1V136
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorGABA| glutamic acid decarboxylase(GAD)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number226907-52-4
-
Formula Weight315.333
-
Molecular FormulaC15H17N5O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (396.41 mM)
-
SMILESCOCCOc1nc(N)c2nc(O)n(Cc3ccccc3)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Abshire VM, et al. Injection of L-allylglycine into the posterior hypothalamus in rats causes decreases in local GABA which correlate with increases in heart rate. Neuropharmacology. 1988 Nov;27(11):1171-7.
molnova catalog
related products
-
Enpatoran
Enpatoran is an inhibitor of TLR7(IC50 = 11.1 nM) and TLR8(IC50 = 24.1 nM). Enpatoran was found to be inactive against TLR3, TLR4, and TLR9 in vitro and in vivo.
-
ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE(receptor for advanced glycation end products) and TLR4 (toll-like receptor 4). ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI).
-
Pam2CSK4
Toll-like receptor 2/6 (TLR2/6) agonist. Induces TNF-α production in human mononuclear cells. Also induces proliferation and activation of mouse splenic B cells.
